By utilizing angiotensin-converting enzyme 2 (ACE2), the cellular receptor for SARS-CoV-2, they effectively determined the SARS-CoV-2 S1 antigen from COVID-19 patients extracted clinical specimens (Figure 7A) [122,123]. This evidence concerns the gene ACE2 and COVID-19.